Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 81
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Infect Chemother ; 30(9): 942-945, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38369124

RESUMEN

The fungus Wickerhamiella pararugosa (Candida pararugosa) has been detected in various human organs but has rarely caused bloodstream infections. This report presents a case of central venous catheter-related bloodstream infection (CRBSI) of W. pararugosa in an adult. A female patient in her 80s was admitted to our facility for intestinal obstruction caused by colorectal cancer. The patient's ability to consume food was hindered, necessitating the insertion of a central venous catheter (CVC) into the internal jugular vein. On day 3 after admission, the patient developed a fever, prompting blood and CVC tip cultures to be performed. On day 5, yeast-like fungi were discovered in the blood cultures, and fosfluconazole (fluconazole [FLCZ] pro-drug) treatment was initiated. On day 8, yeast-like fungi were identified in both the blood and CVC tip cultures, leading to a diagnosis of CRBSI. The fungus was identified as W. pararugosa through biochemical and genetic characterization. This finding justified the use of micafungin (MCFG) for combination therapy. On day 17, the minimum inhibitory concentrations (MIC) for FLCZ and MCFG were 4-8 and 0.06 µg/mL, respectively. Accordingly, the treatment was changed to monotherapy with MCFG. After a 21-day treatment regimen, the patient was discharged on day 31. We present a case of CRBSI caused by W. pararugosa in an adult with intestinal obstruction. The notable increase in the MIC of FLCZ necessitated monotherapy with MCFG, which resulted in successful recovery of the patient.


Asunto(s)
Antifúngicos , Obstrucción Intestinal , Humanos , Femenino , Obstrucción Intestinal/microbiología , Obstrucción Intestinal/etiología , Antifúngicos/uso terapéutico , Anciano de 80 o más Años , Infecciones Relacionadas con Catéteres/microbiología , Infecciones Relacionadas con Catéteres/tratamiento farmacológico , Infecciones Relacionadas con Catéteres/diagnóstico , Pruebas de Sensibilidad Microbiana , Fluconazol/uso terapéutico , Candida/aislamiento & purificación , Candida/efectos de los fármacos , Catéteres Venosos Centrales/efectos adversos , Catéteres Venosos Centrales/microbiología , Micafungina/uso terapéutico , Neoplasias Colorrectales/complicaciones , Neoplasias Colorrectales/microbiología , Candidemia/tratamiento farmacológico , Candidemia/diagnóstico , Candidemia/microbiología , Candidemia/complicaciones
2.
Int J Med Sci ; 20(1): 136-141, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36619223

RESUMEN

Objectives: There are currently no appropriate markers and target for prophylaxis against COVID-19-related thrombosis, especially in the not-severe cases. We tested the hypothesis that inflammation is a suitable marker and target for prophylaxis against COVID-19-related thrombosis. Methods: Data of all 32 COVID-19 patients admitted to Saitama Medical Center between January 1 and March 30, 2021, were analyzed. Patients were divided into severe (requiring oxygen, n=12) and non-severe (no requirement for oxygen, n=20), and also those with high C-reactive protein (CRP) level (cutoff value: 30 mg/L, n=21) and low-CRP (n=11). We also compared the clinical and laboratory data of a 46-year-old post-liver transplant male patient, who was treated with a combination of immunosuppressants (methylprednisolone, fludrocortisone, cyclosporine, and everolimus) with those of other COVID-19 patients, using the Smirnoff-Grubbs and Box plots tests. Results: The levels of CRP, ferritin, lactate dehydrogenase, aspartate aminotransferase, and thrombin-antithrombin complex (TAT) were significantly higher in the high-severity group than the low-severity group; while other coagulation parameters were comparable. The time between onset of illness and blood levels of lactate dehydrogenase, fibrinogen, D-dimer, TAT, and plasmin alpha2-plasmin inhibitor complex (PIC) were significantly higher whereas lymphocyte count was significantly lower in the high-CRP group. Extremely low levels of TAT, PIC, and plasminogen activator inhibitor-1 (PAI-1) were recorded in the liver transplant patient treated with immunosuppressants. The TAT, PIC, and PAI-1 levels were deemed outliers. Conclusions: Inflammation is a potentially suitable marker and target for prophylaxis against COVID-19-related thrombosis.


Asunto(s)
COVID-19 , Trombosis , Humanos , Masculino , Persona de Mediana Edad , COVID-19/complicaciones , Inhibidor 1 de Activador Plasminogénico , Inflamación/tratamiento farmacológico , Trombosis/tratamiento farmacológico , Trombosis/etiología , Trombosis/prevención & control , Oxígeno , Inmunosupresores , Lactato Deshidrogenasas
3.
Kyobu Geka ; 75(2): 111-113, 2022 Feb.
Artículo en Japonés | MEDLINE | ID: mdl-35249086

RESUMEN

We report a case of delayed hemolytic transfusion reaction (DHTR) after mitral valve replacement (MVR). A 67-year-old woman with a history of blood transfusion( BT) was admitted for MVR. Preoperative laboratory test proved to be negative for irregular antibodies except anti-Dia. She underwent MVR using a mechanical prosthesis and compatible blood products were transfused perioperatively. On post-operative day 13, she developed hemoglobinuria and anemia with elevated serum total bilirubin and lactic dehydrogenase levels. Transesophageal echocardiography showed trivial transvalvular leakage. Laboratory test successfuly identified another irregular antibody, anti-Jkb antibody. The patient had Jkb negative BT and did not need re-operation. Later, she recovered with no signs of hemolysis. Since anti-Jkb antibody gets undetectable within a few months, it is difficult to find out before surgery. As hemolysis following cardiac surgery is more commonly associated with prostheses and extracorporeal circulation than DHTR. Physicians should, however, be aware of this unusual complication especially in patients who underwent BT.


Asunto(s)
Anemia Hemolítica , Reacción a la Transfusión , Anciano , Anemia Hemolítica/etiología , Transfusión Sanguínea , Femenino , Hemólisis , Humanos , Isoanticuerpos , Válvula Mitral/cirugía , Reacción a la Transfusión/complicaciones
4.
J Infect Chemother ; 27(11): 1653-1657, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34147356

RESUMEN

Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is endemic in specific regions, including Southeast Asia and Northern Australia. In Japan, where no autochthonous has been reported to date, melioidosis is a rare infectious disease. Herein, we report a case of melioidosis in a 68-year-old Japanese man with renal abscess and bacteremia, but without pneumonia. The patient presented to our hospital and was admitted for fever and chills that have persisted for two months. It was speculated that he was infected in Thailand, where his family lives because he shuttled between Thailand and Japan. Blood cultures on admission identified Burkholderia species; however, the species was unidentifiable by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Further re-examination, including culture, loop-mediated isothermal amplification, and multiplex polymerase chain reaction methods, finally identified Burkholderia pseudomallei. We treated the patient with intravenous ceftazidime for four weeks. In addition to the antibiotics administration, puncture drainage of the renal abscess was performed, and he gradually became afebrile. Intravenous ceftazidime was switched to oral sulfamethoxazole/trimethoprim on post-admission day 32, and he was discharged. After five months of oral sulfamethoxazole/trimethoprim, no recurrence was observed one year after discharge. To diagnose melioidosis, especially in non-endemic areas, a precise and thorough understanding of its epidemiology, presentation, and identification methods is necessary.


Asunto(s)
Bacteriemia , Burkholderia pseudomallei , Melioidosis , Absceso , Anciano , Antibacterianos/uso terapéutico , Bacteriemia/diagnóstico , Bacteriemia/tratamiento farmacológico , Burkholderia pseudomallei/genética , Humanos , Japón , Masculino , Melioidosis/diagnóstico , Melioidosis/tratamiento farmacológico , Técnicas de Diagnóstico Molecular , Técnicas de Amplificación de Ácido Nucleico , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
5.
BMC Infect Dis ; 19(1): 927, 2019 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-31684875

RESUMEN

BACKGROUND: Capnocytophaga canimorsus is a gram-negative bacterium and an oral commensal in dogs and cats, but occasionally causes serious infections in humans. Septicemia is one of the most fulminant forms, but diagnosis of C. canimorsus infection is often difficult mainly because of its very slow growth. C. canimorsus infective endocarditis (IE) is rare and is poorly understood. Since quite a few strains produce ß-lactamase, antimicrobial susceptibility is pivotal information for adequate treatment. We herein report a case with C. canimorsus IE and the results of drug susceptibility test. CASE PRESENTATION: A 46-year-old man had a dog bite in his left hand 3 months previously. The patient was referred to our hospital for fever (body temperature > 38 °C), visual disturbance, and dyspnea. Echocardiography showed aortic valve regurgitation and vegetation on the leaflets. IE was diagnosed, and we initially administered cefazolin and gentamycin assuming frequently encountered microorganisms and the patient underwent aortic valve replacement. C. canimorsus was detected in the aortic valve lesion and blood cultures. It was also identified by 16S ribosome DNA sequencing. Ceftriaxone were started and continued because disk diffusion test revealed the isolate was negative for ß-lactamase and this case had cerebral symptoms. The patient successfully completed antibiotic treatment following surgery. CONCLUSIONS: We diagnosed C. canimorsus sepsis and IE by extended-period blood cultures and 16S ribosome DNA sequencing by polymerase chain reaction, and successfully identified its drug susceptibility.


Asunto(s)
Mordeduras y Picaduras/complicaciones , Capnocytophaga/patogenicidad , Endocarditis Bacteriana/etiología , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/etiología , Infecciones por Bacterias Gramnegativas/terapia , Animales , Antibacterianos/uso terapéutico , Cultivo de Sangre , Capnocytophaga/genética , Cefazolina/uso terapéutico , Ceftriaxona/uso terapéutico , Perros , Endocarditis Bacteriana/tratamiento farmacológico , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/terapia , Gentamicinas/uso terapéutico , Infecciones por Bacterias Gramnegativas/microbiología , Prótesis Valvulares Cardíacas , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa/métodos , Sepsis/tratamiento farmacológico , beta-Lactamasas
6.
Malar J ; 17(1): 217, 2018 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-29843734

RESUMEN

BACKGROUND: The recent spread of artemisinin (ART)-resistant Plasmodium falciparum represents an emerging global threat to public health. In Southeast Asia, the C580Y mutation of kelch13 (k13) is the dominant mutation of ART-resistant P. falciparum. Therefore, a simple method for the detection of C580Y mutation is urgently needed to enable widespread routine surveillance in the field. The aim of this study is to develop a new diagnostic procedure for the C580Y mutation using loop-mediated isothermal amplification (LAMP) combined with the MinION nanopore sequencer. RESULTS: A LAMP assay for the k13 gene of P. falciparum to detect the C580Y mutation was successfully developed. The detection limit of this procedure was 10 copies of the reference plasmid harboring the k13 gene within 60 min. Thereafter, amplicon sequencing of the LAMP products using the MinION nanopore sequencer was performed to clarify the nucleotide sequences of the gene. The C580Y mutation was identified based on the sequence data collected from MinION reads 30 min after the start of sequencing. Further, clinical evaluation of the LAMP assay in 34 human blood samples collected from patients with P. falciparum malaria in Indonesia revealed a positive detection rate of 100%. All LAMP amplicons of up to 12 specimens were simultaneously sequenced using MinION. The results of sequencing were consistent with those of the conventional PCR and Sanger sequencing protocol. All procedures from DNA extraction to variant calling were completed within 3 h. The C580Y mutation was not found among these 34 P. falciparum isolates in Indonesia. CONCLUSIONS: An innovative method combining LAMP and MinION will enable simple, rapid, and high-sensitivity detection of the C580Y mutation of P. falciparum, even in resource-limited situations in developing countries.


Asunto(s)
Malaria Falciparum/clasificación , Mutación , Técnicas de Amplificación de Ácido Nucleico/métodos , Plasmodium falciparum/genética , Proteínas Protozoarias/genética , Humanos , Indonesia , Malaria Falciparum/parasitología , Nanoporos , Plasmodium falciparum/aislamiento & purificación
7.
Med Mycol ; 56(3): 382-386, 2018 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-28992282

RESUMEN

The efficacy of recombinant interferon γ (rIFN-γ) for cryptococcal meningoencephalitis has been poorly understood. Compared to Cryptococcus gattii, rIFN-γ significantly improved the survival in experimental meningoencephalitis due to Cryptococcus neoformans. The number of phagocytic macrophages and the levels of inflammatory cytokines production for ex vivo co-incubation with C. neoformans were increased after rIFN-γ stimulation but not C. gattii. Intraspecies differences of phagocytosis by the rIFN-γ-activated macrophages might be associated to the severity of cryptococcal infection.


Asunto(s)
Interferón gamma/uso terapéutico , Macrófagos/efectos de los fármacos , Meningoencefalitis/tratamiento farmacológico , Animales , Antifúngicos/farmacología , Antifúngicos/uso terapéutico , Línea Celular , Recuento de Colonia Microbiana , Cryptococcus gattii/efectos de los fármacos , Cryptococcus gattii/patogenicidad , Cryptococcus neoformans/efectos de los fármacos , Cryptococcus neoformans/patogenicidad , Modelos Animales de Enfermedad , Femenino , Interferón gamma/farmacología , Macrófagos/citología , Macrófagos/metabolismo , Meningoencefalitis/microbiología , Meningoencefalitis/mortalidad , Meningoencefalitis/patología , Ratones , Ratones Endogámicos C57BL , Fagocitosis/efectos de los fármacos , Especificidad de la Especie , Tasa de Supervivencia , Virulencia
8.
Artículo en Inglés | MEDLINE | ID: mdl-28115352

RESUMEN

Few data on breakthrough candidemia (BC), defined as candidemia that develops on administration of antifungal agents (AFAs), in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients are available. The medical and microbiological records of recipients of an allo-HSCT obtained between December 2008 and December 2014 were reviewed. Of 768 allo-HSCT cases, 26 developed BC. Among the 26 causative strains, 22 strains were stored and identified by sequencing. The following species were isolated: Candida parapsilosis (9 strains), C. glabrata (4 strains), C. guilliermondii (3 strains), and other Candida species (6 strains). The AFAs being used when BC developed were micafungin (17 cases), liposomal amphotericin B (5 cases), itraconazole (2 cases), and voriconazole (2 cases). All 17 cases who developed BC during micafungin administration were administered 150 mg/day of micafungin. The susceptibilities of the causative Candida species to the administered AFAs when breakthrough occurred ranged from susceptible to resistant. Especially, 85% of the Candida species that caused BC during micafungin administration were susceptible to micafungin. Additionally, 75% of the strains were wild type for susceptibility to the administered AFAs when breakthrough occurred. Systemic steroid administration and a longer severe neutropenic phase (≥5 days) were independent risk factors for BC (P = 0.016 and P = 0.015, respectively). BC developed in allo-HSCT recipients even when they received a sufficient dose of AFA, including micafungin, to which the causative Candida species were susceptible and/or had wild-type susceptibility in vitro Systemic steroid administration and a longer severe neutropenic phase were host-based factors associated with BC.


Asunto(s)
Antifúngicos/farmacología , Candida/patogenicidad , Candidemia/microbiología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Adolescente , Adulto , Anciano , Anfotericina B/farmacología , Antineoplásicos/uso terapéutico , Candida/clasificación , Candida/crecimiento & desarrollo , Candidemia/tratamiento farmacológico , Candidemia/etiología , Candidemia/patología , Equinocandinas/farmacología , Femenino , Neoplasias Hematológicas/patología , Neoplasias Hematológicas/terapia , Hospitales , Humanos , Itraconazol/farmacología , Japón , Lipopéptidos/farmacología , Masculino , Micafungina , Persona de Mediana Edad , Neutropenia/patología , Factores de Riesgo , Esteroides/administración & dosificación , Acondicionamiento Pretrasplante/métodos , Trasplante Homólogo , Voriconazol/farmacología
9.
Mycopathologia ; 182(9-10): 847-853, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28577122

RESUMEN

Infection caused by Cunninghamella bertholletiae carries one of the highest mortality rates among mucormycosis, and there are no reported cases that survived from the infection in allogeneic hematopoietic stem cell transplantation recipients occurring before neutrophil engraftment. Here, we present two cases of pulmonary mucormycosis caused by C. bertholletiae occurring before neutrophil engraftment after cord blood transplantation. Both were successfully treated with high-dose liposomal amphotericin B (10 mg/kg/day) combined with micafungin, which was then followed by neutrophil recovery, reduction in immunosuppressive agents, and a subsequent lobectomy. The intensive antifungal therapy immediately administered upon suspicion of mucormycosis greatly suppressed the infection in its early stage and was well tolerated despite its prolonged administration and simultaneous use of nephrotoxic agents after transplantation. Although the synergic effect of micafungin remains unclear, these cases highlight the importance of prompt administration of high-dose lipid polyene when suspecting mucormycosis in highly immunocompromised patients, which enables subsequent diagnostic and therapeutic interventions, resulting in a favorable outcome.


Asunto(s)
Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Cunninghamella/aislamiento & purificación , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/cirugía , Mucormicosis/tratamiento farmacológico , Mucormicosis/cirugía , Adulto , Anciano , Trasplante de Células Madre de Sangre del Cordón Umbilical/efectos adversos , Quimioterapia Combinada , Equinocandinas/administración & dosificación , Femenino , Humanos , Huésped Inmunocomprometido , Inmunosupresores/administración & dosificación , Inmunosupresores/efectos adversos , Lipopéptidos/administración & dosificación , Pulmón/cirugía , Enfermedades Pulmonares Fúngicas/diagnóstico , Enfermedades Pulmonares Fúngicas/microbiología , Masculino , Micafungina , Mucormicosis/diagnóstico , Mucormicosis/microbiología , Receptores de Trasplantes , Resultado del Tratamiento
10.
J Infect Chemother ; 22(1): 32-5, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26603481

RESUMEN

In comparison to the conventional real-time polymerase chain reaction method (PCR method) or the DNA-DNA hybridization method (DDH method), the utility of NTM identification by the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) method has seldom been reported. In this study, 75 clinical NTM isolates from our hospital between April 2013 and July 2014 were identified and analyzed using PCR, DDH, and MALDI-TOF MS methods, and the results for the MALDI-TOF MS method were compared with the others. Identification at the species level was in agreement for 71 (94.5%) of the 75 isolates. For further details, identification was possible for 23 (95.8%) of 24 Mycobacterium avium, 11 (100%) of 11 Mycobacterium intracellulare, and 1 (50%) of 2 isolates mixed with M. avium and M. intracellulare. Mycobacterium ksansasii, Mycobacterium abscessus, Mycobacterium fortuitum, Mycobacterium gordonae, and Mycobacterium chelonae identified by DDH method were same result by MALDI-TOF MS. Additionally, Mycobacterium mucogenicum, which could not be identified by the DDH method, was identified by the MALDI-TOF MS method. However, two isolates identified as Mycobacterium terrae by DDH method could not be identified by the MALDI-TOF MS method and were determined to be Mycobacterium arupense by 16S ribosomal RNA (rRNA) sequence analysis. The present findings show that, for rare bacterial species, identification is sometimes not possible, but, in most cases, the results of identification by the MALDI-TOF MS method have a high concordance rate with the results of the PCR and DDH methods.


Asunto(s)
Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/microbiología , Micobacterias no Tuberculosas/aislamiento & purificación , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Humanos , Japón , Mycobacterium avium/aislamiento & purificación , Complejo Mycobacterium avium/aislamiento & purificación , Mycobacterium chelonae/aislamiento & purificación , Mycobacterium fortuitum/aislamiento & purificación , Mycobacterium kansasii/aislamiento & purificación , Hibridación de Ácido Nucleico , ARN Ribosómico 16S , Reacción en Cadena en Tiempo Real de la Polimerasa , Sensibilidad y Especificidad
11.
Infect Immun ; 83(4): 1577-86, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25644007

RESUMEN

Cryptococcosis due to a highly virulent fungus, Cryptococcus gattii, emerged as an infectious disease on Vancouver Island in Canada and surrounding areas in 1999, causing deaths among immunocompetent individuals. Previous studies indicated that C. gattii strain R265 isolated from the Canadian outbreak had immune avoidance or immune suppression capabilities. However, protective immunity against C. gattii has not been identified. In this study, we used a gain-of-function approach to investigate the protective immunity against C. gattii infection using a dendritic cell (DC)-based vaccine. Bone marrow-derived dendritic cells (BMDCs) efficiently engulfed acapsular C. gattii (Δcap60 strain), which resulted in their expression of costimulatory molecules and inflammatory cytokines. This was not observed for BMDCs that were cultured with encapsulated strains. When Δcap60 strain-pulsed BMDCs were transferred to mice prior to intratracheal R265 infection, significant amelioration of pathology, fungal burden, and the survival rate resulted compared with those in controls. Multinucleated giant cells (MGCs) that engulfed fungal cells were significantly increased in the lungs of immunized mice. Interleukin 17A (IL-17A)-, gamma interferon (IFN-γ)-, and tumor necrosis factor alpha (TNF-α)-producing lymphocytes were significantly increased in the spleens and lungs of immunized mice. The protective effect of this DC vaccine was significantly reduced in IFN-γ knockout mice. These results demonstrated that an increase in cytokine-producing lymphocytes and the development of MGCs that engulfed fungal cells were associated with the protection against pulmonary infection with highly virulent C. gattii and suggested that IFN-γ may have been an important mediator for this vaccine-induced protection.


Asunto(s)
Criptococosis/inmunología , Cryptococcus gattii/inmunología , Células Dendríticas/trasplante , Cápsulas Fúngicas/inmunología , Vacunas Fúngicas/inmunología , Animales , Células de la Médula Ósea/inmunología , Tratamiento Basado en Trasplante de Células y Tejidos , Criptococosis/prevención & control , Células Dendríticas/inmunología , Cápsulas Fúngicas/genética , Células Gigantes/inmunología , Interferón gamma/genética , Interferón gamma/inmunología , Interleucina-17/inmunología , Pulmón/inmunología , Pulmón/microbiología , Linfocitos/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Factor de Necrosis Tumoral alfa/inmunología , Vacunación
12.
J Infect Chemother ; 21(5): 392-4, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25499194

RESUMEN

We describe a case of central venous catheter-related fungemia caused by Cryptococcus liquefaciens, a non-neoformans and non-gattii Cryptococcus, in a non-HIV patient. A 71-year-old man with diffuse large B-cell lymphoma receiving antineoplastic chemotherapy was febrile approximately 30 weeks after central venous port insertion, and C. liquefaciens was isolated from all three performed blood cultures as well as a central venous catheter tip culture. In vitro antifungal susceptibility tests showed that this yeast isolate was susceptible to low concentrations of amphotericin B, fluconazole, itraconazole and voriconazole yet was resistant to 5-fluorocytosine (MIC: >64 µg/ml), unlike Cryptococcus neoformans. Treatment of the patient with oral and intravenous voriconazole was effective and consistent with the susceptibility tests. Although non-neoformans and non-gattii Cryptococcus spp. are considered non-pathogenic environmental yeast, they may rarely be the causative agents of serious infections in humans, as in the present case.


Asunto(s)
Infecciones Relacionadas con Catéteres/microbiología , Catéteres Venosos Centrales/efectos adversos , Criptococosis/microbiología , Fungemia/microbiología , Anciano , Infecciones Relacionadas con Catéteres/tratamiento farmacológico , Catéteres Venosos Centrales/microbiología , Criptococosis/tratamiento farmacológico , Fungemia/tratamiento farmacológico , Humanos , Masculino
13.
J Infect Chemother ; 21(12): 831-6, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26477011

RESUMEN

Among invasive fungal infections, cryptococcosis caused by inhalation of Cryptococcus neoformans or Cryptococcus gattii is particularly dangerous because it can disseminate to the central nervous system and cause life-threatening meningitis or meningoencephalitis. Previous reports described significant differences in the histopathological features of C. neoformans and C. gattii infection, such as greater pathogen proliferation and a limited macrophage response in mouse lung infected by C. gattii. To elucidate the difference in pathogenicity of these two Cryptococcus species, we investigated the interaction of C. neoformans and C. gattii with murine macrophages, the first line of host defense, by confocal laser microscopy. Only thin-capsulated, and not thick-capsulated C. neoformans and C. gattii were phagocytosed by macrophages. Preactivation with interferon-γ increased the phagocytic rate of thin-capsulated C. neoformans up to two-fold, but did not promote phagocytosis of thin-capsulated C. gattii. Lipopolysaccharide preactivation or Aspergillus fumigatus conidia co-incubation had no effect on internalization of thin-capsulated C. neoformans or C. gattii by macrophages. Phagocytosis of live thin-capsulated C. neoformans, but not that of live thin-capsulated C. gattii, induced interleukin-12 release from macrophages. However, phagocytosis of heat-killed or paraformaldehyde-fixed thin-capsulated C. neoformans did not increase IL-12 release, showing that the internalization of live yeast is important for initiating the immune response during C. neoformans-macrophage interactions. Our data suggest that macrophage response to C. gattii is limited compared with that to C. neoformans and that these results may partially explain the limited immune response and the greater pathogenicity of C. gattii.


Asunto(s)
Criptococosis/tratamiento farmacológico , Cryptococcus gattii/efectos de los fármacos , Cryptococcus neoformans/efectos de los fármacos , Interferón gamma/farmacología , Fagocitosis/efectos de los fármacos , Animales , Línea Celular , Criptococosis/metabolismo , Criptococosis/microbiología , Interleucina-12/metabolismo , Lipopolisacáridos/farmacología , Pulmón/metabolismo , Pulmón/microbiología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones
14.
J Infect Chemother ; 21(6): 479-81, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25828927

RESUMEN

We report a patient with severe invasive pulmonary fungal infection caused by Aspergilllus lentulus, which was identified by genetic analysis, following liver transplantation. The patient was initially suspected to have Aspergilllus fumigatus infection, but worsened clinically despite antifungal therapy appropriate for that species. The patient survived after accurate diagnosis, and detailed drug susceptibility testing led to adequate therapy, demonstrating the importance of performing these investigations for severely immunocompromised patients, including organ transplant recipients.


Asunto(s)
Antifúngicos/uso terapéutico , Aspergillus/efectos de los fármacos , Aspergilosis Pulmonar Invasiva/tratamiento farmacológico , Aspergilosis Pulmonar Invasiva/microbiología , Trasplante de Hígado/efectos adversos , Humanos , Huésped Inmunocomprometido/efectos de los fármacos , Masculino , Persona de Mediana Edad
15.
Mol Microbiol ; 88(2): 371-81, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23448689

RESUMEN

During disseminated infection by the opportunistic pathogen Candida glabrata, uptake of sterols such as serum cholesterol may play a significant role during pathogenesis. The ATP-binding cassette transporter Aus1p is thought to function as a sterol importer and in this study, we show that uptake of exogenous sterols occurred under anaerobic conditions in wild-type cells of C. glabrata but not in AUS1-deleted mutant (aus1Δ) cells. In aerobic cultures, growth inhibition by fluconazole was prevented in the presence of serum, and AUS1 expression was upregulated. Uptake of sterol by azole treated cells required the presence of serum, and sterol alone did not reverse FLC inhibition of growth. However, if iron availability in the growth medium was limited by addition of the iron chelators ferrozine or apo-transferrin, growth of wild-type cells, but not aus1Δ cells, was rescued. In a mouse model of disseminated infection, the C. glabrata aus1Δ strain caused a significantly decreased kidney fungal burden than the wild-type strain or a strain in which AUS1 was restored. We conclude that sterol uptake in C. glabrata can occur in iron poor environment of host tissues and thus may contribute to C. glabrata pathogenesis.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Candida glabrata/metabolismo , Candida glabrata/patogenicidad , Regulación Fúngica de la Expresión Génica , Hierro/metabolismo , Esteroles/metabolismo , Transportadoras de Casetes de Unión a ATP/genética , Aerobiosis , Anaerobiosis , Animales , Candida glabrata/genética , Candidiasis/microbiología , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Eliminación de Gen , Regulación Fúngica de la Expresión Génica/efectos de los fármacos , Riñón/microbiología , Masculino , Ratones , Ratones Endogámicos BALB C , Bazo/microbiología
16.
J Infect Chemother ; 20(10): 612-5, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25009090

RESUMEN

Fluconazole (FLCZ) is a first-line drug for treating Candida albicans infections, but clinical failure due to reduced sensitivity is a growing concern. Our previous study suggested that certain drug combinations pose a particular challenge in potently reducing FLCZ's anti-C. albicans activity, and cyclooxygenase inhibitors formed the major group of these attenuating drugs in combination with FLCZ. In this study, we examined the effects of diclofenac sodium (DFNa) and related compounds in combination with FLCZ against C. albicans, and investigated their possible mechanisms of interaction. DFNa, ibuprofen, and omeprazole elevated the minimum inhibitory concentration (MIC) of FLCZ by 8-, 4-, and 4-fold, respectively; however, loxoprofen sodium and celecoxib did not. An analogue of DFNa, 2,6-dichlorodiphenylamine, also elevated the MIC by 4-fold. Gene expression analysis revealed that diclofenac sodium induced CDR1 efflux pump activity, but not CDR2 activity. In addition, an efflux pump CDR1 mutant, which was manipulated to not be induced by DFNa, showed less elevation of MIC compared to that shown by the wild type. Therefore, DFNa and related compounds are potent factors for reducing the sensitivity of C. albicans to FLCZ partly via induction of an efflux pump. Although it is not known whether such antagonism is relevant to the clinical treatment failure observed, further investigation of the molecular mechanisms underlying the reduction of FLCZ's anti-C. albicans activity is expected to promote safer and more effective use of the drug.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Inhibidores de la Ciclooxigenasa/farmacología , Fluconazol/antagonistas & inhibidores , Transportadoras de Casetes de Unión a ATP/genética , Candida albicans/genética , Celecoxib/farmacología , Diclofenaco/farmacología , Fluconazol/uso terapéutico , Proteínas Fúngicas/genética , Expresión Génica/efectos de los fármacos , Ibuprofeno/farmacología , Proteínas de Transporte de Membrana/genética , Pruebas de Sensibilidad Microbiana , Omeprazol/farmacología , Fenilpropionatos/farmacología , Inhibidores de la Bomba de Protones/farmacología
17.
Kansenshogaku Zasshi ; 88(3 Suppl 9-10): 6-10, 2014 May.
Artículo en Japonés | MEDLINE | ID: mdl-24979950

RESUMEN

Candida glabrata was continuously isolated in cultured urine samples from a subject with thrombotic thrombocytopenic purpura. Yeast-like fungal phagocytosis found in gram staining led to agents being tested for antifungal susceptibility, revealing hyposensitivity to micafungin (MCFG) of MIC < 2 mg/mL. MCFG administered for 10 days failed to cure C. glabrata infection. To clarify why hyposensitivity occurred, we analyzed the FKS gene sequence using the PCR, finding a deficit of 3 bases coding phenylalanine at FKS2 gene amino acid 659. MCFG hyposensitivity may thus occur in long-term candin-class anti-fungal agent treatment. Candin-class agents have potent anti-fungal activity with fewer adverse effects and are widely used clinically. Hyposensitivity due to resistant C. glabrata species showed thus be considered in fungal infection treatment.


Asunto(s)
Antifúngicos/farmacología , Candida glabrata/efectos de los fármacos , Candida glabrata/genética , Farmacorresistencia Fúngica , Equinocandinas/farmacología , Genes Fúngicos/genética , Lipopéptidos/farmacología , Mutación , Anciano , Femenino , Proteínas Fúngicas/genética , Glucosiltransferasas/genética , Humanos , Proteínas de la Membrana/genética , Micafungina
18.
Jpn J Antibiot ; 67(4): 215-21, 2014 Aug.
Artículo en Japonés | MEDLINE | ID: mdl-25420317

RESUMEN

We investigated the susceptibility of Candida species from clinical aseptic samples, including blood, at some hospitals in Saitama prefecture. Candida spp. detected from aseptic samples in the 6 institutes in Saitama prefecture from November 2007 to July 2011 were studied. The number of isolates was 85, which are 43 (50.6%) of Candida albicans, 24 (28.2%) of Candida parapsilosis, 5 (5.9%) of Candida glabrata, 5 (5.9%) of Candida tropicalis, 4 (4.7%) of Candida guilliermondii, 2 (2.4%) of Candida fermentati, 1 (1.2%) of Candida famata and Candida lusitaniae, respectively. All isolates were susceptible to amphotericin B. However, resistant isolates against micafungin were 3 in 5 of C. glabrata. We analyzed susceptibility of Candida spp. in Saitama prefecture in the article, and our study might be useful for the fungal therapy in the region.


Asunto(s)
Antifúngicos/farmacología , Candida/efectos de los fármacos , Candidiasis/microbiología , Farmacorresistencia Fúngica , Candida/citología , Candida/aislamiento & purificación , Humanos , Japón , Pruebas de Sensibilidad Microbiana
19.
Antimicrob Agents Chemother ; 57(5): 2226-30, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23459484

RESUMEN

To understand the process of Candida biofilm development and the effects of antifungal agents on biofilms, we analyzed real-time data comprising time-lapse images taken at times separated by brief intervals. The growth rate was calculated by measuring the change of biofilm thickness every hour. For the antifungal study, 5-h-old biofilms of Candida albicans were treated with either micafungin (MCFG) or fluconazole (FLCZ). MCFG began to suppress biofilm growth a few minutes after the initiation of the treatment, and this effect was maintained over the course of the observation period. In contrast, the suppressive effects of FLCZ on biofilm growth took longer to manifest: biofilms grew in the first 5 h after treatment, and then their growth was suppressed over the next 10 h, finally producing results similar to those observed with MCFG. MCFG was also involved in the disruption of cells in the biofilms, releasing string-like structures (undefined extracellular component) from the burst hyphae. Thus, MCFG inhibited the detachment of yeast cell clusters from the tips of hyphae. In contrast, FLCZ did not disrupt biofilm cells. MCFG also showed fast antifungal activity against Candida parapsilosis biofilms. In conclusion, our results show that inhibition of glucan synthesis due to MCFG contributed not only to fungicidal activity but also to the immediate suppression of biofilm growth, while FLCZ suppressed growth by inhibiting ergosterol synthesis. Therefore, those characteristic differences should be considered when treating clinical biofilm infections.


Asunto(s)
Antifúngicos/farmacología , Biopelículas/efectos de los fármacos , Candida albicans/efectos de los fármacos , Equinocandinas/farmacología , Fluconazol/farmacología , Lipopéptidos/farmacología , Imagen de Lapso de Tiempo , Biopelículas/crecimiento & desarrollo , Candida albicans/crecimiento & desarrollo , Ergosterol/antagonistas & inhibidores , Ergosterol/biosíntesis , Glucanos/antagonistas & inhibidores , Glucanos/biosíntesis , Hifa/efectos de los fármacos , Hifa/crecimiento & desarrollo , Cinética , Micafungina , Microscopía
20.
Med Mycol ; 51(3): 252-60, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22901045

RESUMEN

Cryptococcosis is primarily caused by two Cryptococcus species, i.e., Cryptococcus neoformans and C. gattii. Both include several genetically diverse subgroups that can be differentiated using various molecular strain typing methods. Since little is known about the molecular epidemiology of the C. neoformans/C. gattii species complex in Japan, we conducted a molecular epidemiological analysis of 35 C. neoformans isolates from non-HIV patients in Nagasaki, Japan and 10 environmental isolates from Thailand. All were analyzed using URA5-restriction fragment length polymorphism (RFLP) and multilocus sequence typing (MLST). Combined sequence data for all isolates were evaluated with the neighbor-joining method. All were found to be serotype A and mating type MATα. Thirty-two of the 35 clinical isolates molecular type VNI, while the three remaining isolates were VNII as determined through the URA5-RFLP method. Thirty-one of the VNI isolates were identified as MLST sequence type (ST) 5, the remaining one was ST 32 and the three VNII isolates were found to be ST 43. All the environmental isolates were identified as molecular type VNI (four MLST ST 5 and six ST 4). Our study shows that C. neoformans isolates in Nagasaki are genetically homogeneous, with most of the isolates being ST 5.


Asunto(s)
Criptococosis/epidemiología , Criptococosis/microbiología , Cryptococcus neoformans/clasificación , Cryptococcus neoformans/genética , Tipificación de Secuencias Multilocus , Técnicas de Tipificación Micológica , Adulto , Anciano , Anciano de 80 o más Años , Análisis por Conglomerados , Cryptococcus neoformans/aislamiento & purificación , Microbiología Ambiental , Femenino , Genes del Tipo Sexual de los Hongos , Genotipo , Humanos , Japón/epidemiología , Masculino , Persona de Mediana Edad , Epidemiología Molecular , Polimorfismo de Longitud del Fragmento de Restricción , Serotipificación , Tailandia/epidemiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA